COMPLEXED PSA MICROTITER ELISA

Antigen(complexed),prostate Specific,(cpsa)

FDA Premarket Approval P990055 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to add a microtiter plate capture system to the current device. The device, as modified, will be marketed under the trade name oncogene science complexed psa microtiter elisa and is indicated for the following: the oncogene science complexed psa microtiter elisa is an in vitro diagnostic assay intended to quantitatively measure complexed psa (cpsa) in human serum. This device is indicated for the measurement of serum cpsa in conjunction with digital rectal exam (dre) as an aid in the detection of prostate cancer in men aged 50 years and older. Prostate biopsy is required for the diagnosis of prostate cancer. The oncogene science complexed psa microtiter elisa is further indicated for follow-up and monitoring of patients with prostate cancer. Cpsa levels measured by this device should be used in conjunction with information available from clinical and other diagnostic procedures in the management of prostate cancer patients.

DeviceCOMPLEXED PSA MICROTITER ELISA
Classification NameAntigen(complexed),prostate Specific,(cpsa)
Generic NameAntigen(complexed),prostate Specific,(cpsa)
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received2001-09-20
Decision Date2002-03-19
PMAP990055
SupplementS002
Product CodeNAF
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516

Supplemental Filings

Supplement NumberDateSupplement Type
P990055Original Filing
S024 2022-03-22 30-day Notice
S023 2021-04-01 30-day Notice
S022 2020-07-31 30-day Notice
S021 2020-03-09 30-day Notice
S020 2020-02-21 30-day Notice
S019
S018 2019-02-01 30-day Notice
S017 2018-07-27 Real-time Process
S016 2017-09-29 Normal 180 Day Track
S015 2015-05-07 Normal 180 Day Track
S014 2012-03-26 Normal 180 Day Track No User Fee
S013 2010-08-06 30-day Notice
S012 2009-04-10 Normal 180 Day Track No User Fee
S011 2009-02-06 30-day Notice
S010 2009-03-06 Real-time Process
S009 2006-05-17 Normal 180 Day Track No User Fee
S008 2005-07-22 Real-time Process
S007 2003-07-16 Real-time Process
S006 2003-04-21 Real-time Process
S005 2002-03-28 Normal 180 Day Track
S004 2002-03-06 Normal 180 Day Track
S003 2001-09-20 Normal 180 Day Track
S002 2001-09-20 Normal 180 Day Track
S001 2001-03-27 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
00630414598710 P990055 001
00630414450896 P990055 001
00630414451114 P990055 001
00630414451558 P990055 001
00630414451732 P990055 001
00630414598475 P990055 001
00630414598680 P990055 001
00630414598697 P990055 001
00630414598703 P990055 001
00630414450872 P990055 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.